General Announcement::Completion of transfer of Company's Active Pharmaceuticals Ingredient (API) Business

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
02-Jan-2019 14:38:51
Status
New
Announcement Sub Title
Completion of transfer of Company's Active Pharmaceuticals Ingredient (API) Business
Announcement Reference
SG190102OTHRC1PC
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Executive Director & Global Chief Financial Officer
Effective Date and Time of the event
02/01/2019 12:00:00
Description (Please provide a detailed description of the event in the box below)
Subject: Completion of transfer of Company's Active Pharmaceuticals Ingredient (API) Business.

Further to the earlier intimation dated October 9, 2018, we hereby inform you that transfer of the Company s API business to Glenmark Life Sciences Limited, a wholly owned subsidiary of the Company, has been completed on December 31, 2018.

Request you to kindly take note of the same.

Attachments

SGX_Completion of transfer.pdf
Total size =433K